"Designing Growth Strategies is in our DNA"

Dermatitis Drugs Market Size, Share and Industry Analysis by Drug Class (Calcineurin Inhibitors, PDE4 Inhibitors, Corticosteroids, Biologics & Others), By Disease Indication (Atopic Dermatitis, Contact Dermatitis & Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Online Pharmacy), and Regional Forecast 2019-2026

Region : Global | Format: PDF | Report ID: FBI100658

 

Table of Content:

1.       Introduction

1.1.     Research Scope

1.2.     Market Segmentation

1.3.     Research Methodology

1.4.     Definitions and Assumptions

2.       Executive Summary

3.       Market Dynamics

3.1.     Market Drivers

3.2.     Market Restraints

3.3.     Market Opportunities

4.       Key Insights

4.1.     Prevalence of majordermatitis types by key countries, 2018

4.2.     Recent industrydevelopments such as mergers & acquisitions

4.3.     Pipeline analysis

4.4.     Patent landscape

4.5.     Reimbursement scenario bykey countries

4.6.     Regulatory scenario for keycountries

5.       Global Dermatitis DrugsMarket Analysis, Insights and Forecast, 2014-2025

5.1.     Key Findings / Summary

5.2.     Market Analysis, Insightsand Forecast – By Drug Class

5.2.1.  Calcineurin Inhibitors

5.2.2.  PDE4 Inhibitors

5.2.3.  Corticosteroids

5.2.4.  Biologics

5.2.5.  Others

5.3.     Market Analysis, Insightsand Forecast – By Disease Indication

5.3.1.  Atopic Dermatitis

5.3.2.  Contact Dermatitis

5.3.3.  Others

5.4.     Market Analysis, Insightsand Forecast – By Distribution Channel

5.4.1.  Hospital Pharmacy

5.4.2.  Retail Pharmacy

5.4.3.  Online Pharmacy

5.5.     Market Analysis, Insightsand Forecast – By Country

5.5.1.  North America

5.5.2.  Europe

5.5.3.  Asia pacific

5.5.4.  Rest of World

6.       North America DermatitisDrugs Market Analysis, Insights and Forecast, 2014-2025

6.1.     Key Findings / Summary

6.2.     Market Analysis – By DrugClass

6.2.1.  Calcineurin Inhibitors

6.2.2.  PDE4 Inhibitors

6.2.3.  Corticosteroids

6.2.4.  Biologics

6.2.5.  Others

6.3.     Market Analysis – ByDisease Indication

6.3.1.  Atopic Dermatitis

6.3.2.  Contact Dermatitis

6.3.3.  Others

6.4.     Market Analysis – ByDistribution Channel

6.4.1.  Hospital Pharmacy

6.4.2.  Retail Pharmacy

6.4.3.  Online Pharmacy

6.5.     Market Analysis – ByCountry

6.5.1.  U.S.

6.5.2.  Canada

7.       Europe Dermatitis DrugsMarket Analysis, Insights and Forecast, 2014-2025

7.1.     Key Findings / Summary

7.2.     Market Analysis – By Drug Class

7.2.1.  Calcineurin Inhibitors

7.2.2.  PDE4 Inhibitors

7.2.3.  Corticosteroids

7.2.4.  Biologics

7.2.5.  Others

7.3.     Market Analysis – ByDisease Indication

7.3.1.  Atopic Dermatitis

7.3.2.  Contact Dermatitis

7.3.3.  Others

7.4.     Market Analysis – ByDistribution Channel

7.4.1.  Hospital Pharmacy

7.4.2.  Retail Pharmacy

7.4.3.  Online Pharmacy

7.5.     Market Analysis – ByCountry

7.5.1.  U.K.

7.5.2.  Germany

7.5.3.  France

7.5.4.  Spain

7.5.5.  Italy

7.5.6.  Scandinavia

7.5.7.  Rest of Europe

8.       Asia pacific DermatitisDrugs Market Analysis, Insights and Forecast, 2014-2025

8.1.     Key Findings / Summary

8.2.     Market Analysis – By DrugClass

8.2.1.  Calcineurin Inhibitors

8.2.2.  PDE4 Inhibitors

8.2.3.  Corticosteroids

8.2.4.  Biologics

8.2.5.  Others

8.3.     Market Analysis – ByDisease Indication

8.3.1.  Atopic Dermatitis

8.3.2.  Contact Dermatitis

8.3.3.  Others

8.4.     Market Analysis – ByDistribution Channel

8.4.1.  Hospital Pharmacy

8.4.2.  Retail Pharmacy

8.4.3.  Online Pharmacy

8.5.     Market Analysis – ByCountry

8.5.1.  Japan

8.5.2.  China

8.5.3.  India

8.5.4.  Australia

8.5.5.  Southeast Asia

8.5.6.  Rest of Asia Pacific

9.       Rest of World DermatitisDrugs Market Analysis, Insights and Forecast, 2014-2025

9.1.     Key Findings / Summary

9.2.     Market Analysis – By DrugClass

9.2.1.  Calcineurin Inhibitors

9.2.2.  PDE4 Inhibitors

9.2.3.  Corticosteroids

9.2.4.  Biologics

9.2.5.  Others

9.3.     Market Analysis – ByDisease Indication

9.3.1.  Atopic Dermatitis

9.3.2.  Contact Dermatitis

9.3.3.  Others

9.4.     Market Analysis – ByDistribution Channel

9.4.1.  Hospital Pharmacy

9.4.2.  Retail Pharmacy

9.4.3.  Online Pharmacy

9.5.     Market Analysis – ByCountry

10.    Competitive Analysis

10.1. Key Industry Developments

10.2. Global Market ShareAnalysis (2017)

10.3. Competition Dashboard

10.4. Comparative Analysis –Major Players

10.5. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies,financials (based on availability))

10.5.1.      Valeant Pharmaceuticals

10.5.2.      Astellas Pharma US, Inc.

10.5.3.      Pfizer, Inc.

10.5.4.      Mylan

10.5.5.      Bayer AG

10.5.6.      Allergan

10.5.7.      LEO Pharma

10.5.8.      Regeneron Pharmaceuticals,Inc.

10.5.9.      Anacor Pharmaceuticals,Inc.

11.    Strategic Recommendations

 

 

 class=
  • Jun, 2019
  • 2018
  • 2015-2017
  • 138

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X